Hepatic disposition of cyclosporine A in isolated perfused rat livers

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 7, Issue 1, 2004, Pages 47-54

  Mehvar, Reza ^a   Chimalakonda, Anjaneya P ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BOLUS INJECTION; CATHETER; CONTROLLED STUDY; DILUTION; DISTRIBUTION VOLUME; DRUG BILE LEVEL; DRUG BINDING SITE; DRUG DISPOSITION; DRUG LIVER LEVEL; DRUG RELEASE; DRUG UPTAKE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOLATED LIVER; LIVER PERFUSION; MALE; NONHUMAN; QUANTITATIVE ASSAY; RAT; STATISTICAL ANALYSIS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; FEMALE; IMMUNOSUPPRESSIVE AGENTS; LIVER; MALE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS;

EID: 2442506851     PISSN: 14821826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Maurer, G., Loosli, H. R., Schreier, E., and Keller, B. Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites. Drug Metab. Dispos. 12: 120-126, 1984.
2. Kronbach, T., Fischer, V., and Meyer, U. A. Cyclosporine metabolism in human liver: Identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin. Pharmacol. Ther. 43: 630-635, 1988.
3. Ptachcinski, R. J., Venkataramanan, R., and Burckart, G. J. Clinical pharmacokinetics of cyclosporin. Clin. Pharmacokinet. 11: 107-132, 1986.
4. Kolars, J. C., Awni, W. M., Merion, R. M., and Watkins, P. B. First-pass metabolism of cyclosporin by the gut. Lancet 338: 1488-1490, 1991.
5. Kolars, J. C., Stetson, P. L., Rush, B. D., Ruwart, M. J., Schmiedlin-Ren, P., Duell, E. A., Voorhees, J. J., and Watkins, P. B. Cyclosporine metabolism by P450IIIA in rat enterocytes--another determinant of oral bioavailability? Transplantation 53: 596-602, 1992.
6. Wu, C. Y., Benet, L. Z., Hebert, M. F., Gupta, S. K., Rowland, M., Gomez, D. Y., and Wacher, V. J. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine. Clin. Pharmacol. Ther. 58: 492-497, 1995.
7. Fahr, A. Cyclosporin clinical pharmacokinetics. Clin. Pharmacokinet. 24: 472-495, 1993.
8. Wagner, O., Schreier, E., Heitz, F., and Maurer, G. Tissue distribution, disposition, and metabolism of cyclosporine in rats. Drug Metab. Dispos. 15: 377-383., 1987.
9. Sangalli, L., Bortolotti, A., Jiritano, L., and Bonati, M. Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans. Drug Metab. Dispos. 16: 749-753, 1988.
10. Molpeceres, J., Chacon, M., Guzman, M., Aberturas, M. R., and Berges, L. Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose. Int. J. Pharm. 197: 129-141, 2000.
11. Wacher, V. J., Liu, T., Roberts, J. P., Ascher, N. L., and Benet, L. Z. Time course of cyclosporine and its metabolites in blood, liver and spleen of naive Lewis rats: Comparison with data obtained in transplanted animals. Biopharm. Drug Dispos. 16: 303-312, 1995.
12. Bernareggi, A. and Rowland, M. Physiologic modeling of cyclosporine kinetics in rat and man. J. Pharmacokinet. Biopharm. 19: 21-50, 1991.
13. Prueksaritanont, T., Koike, M., Hoener, B. A., and Benet, L. Z. Transport and metabolism of cyclosporine in isolated rat hepatocytes. The effects of lipids. Biochem. Pharmacol. 43: 1997-2006., 1992.
14. Smith, J. M., Nemeth, T. L., and McDonald, R. A. Current immunosuppressive agents: efficacy, side effects, and utilization. Pediat. Clin. N. Amer. 50: 1283-1300, 2003.
15. Prueksaritanont, T., Hoener, B. A., and Benet, L. Z. Effects of low-density lipoprotein and ethinyl estradiol on cyclosporine metabolism in isolated rat liver perfusions. Drug Metab. Dispos. 20: 547-552, 1992.
16. Kakutani, T., Yamaoka, K., Hashida, M., and Sezaki, H. A new method for assessment of drug disposition in muscle: Application of statistical moment theory to local perfusion systems. J. Pharmacokinet. Biopharm. 13: 609-631, 1985.
17. Mehvar, R., Robinson, M. A., and Reynolds, J. M. Molecular weight dependent tissue accumulation of dextrans: in vivo studies in rats. J. Pharm. Sci. 83: 1495-1499, 1994.
18. Lee, H. B. and Blaufox, M. D. Blood volume in the rat. J. Nucl. Med. 26: 72-76, 1985.
19. Mehvar, R. and Zhang, X. P. Development and application of an isolated perfused rat liver model to study the stimulation and inhibition of tumor necrosis factor-α production ex vivo. Pharm. Res. 19: 47-53, 2002.
20. Mehvar, R., Reynolds, J. M., Robinson, M. A., and Longstreth, J. A. Enantioselective kinetics of verapamil and norverapamil in isolated perfused rat livers. Pharm. Res. 11: 1815-1819, 1994.
21. Chimalakonda, A. P., Shah, R. B., and Mehvar, R. High-performance liquid chromatographic analysis of cyclosporin A in rat blood and liver using a commercially available internal standard. J. Chromatogr. B 772: 107-114, 2002.
22. Mehvar, R. and Shepard, T. L. Molecular weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats. J. Pharm. Sci. 81: 908-912, 1992.
23. Deters, M., Strubelt, O., and Younes, M. Reevaluation of cyclosporine induced hepatotoxicity in the isolated perfused rat liver. Toxicology 123: 197-206, 1997.
24. Esmore, D., Keogh, A., Spratt, P., Jones, B., and Chang, V. Heart transplantation in females. J. Heart Lung Transplant. 10: 335-341, 1991.
25. Brooks, B. K., Levy, M. F., Jennings, L. W., Abbasoglu, O., Vodapally, M., Goldstein, R. M., Husberg, B. S., Gonwa, T. A., and Klintmalm, G. B. Influence of donor and recipient gender on the outcome of liver transplantation. Transplantation 62: 1784-1787, 1996.
26. Kahan, B. D., Kramer, W. G., Wideman, C., Flechner, S. M., Lorber, M. I., and Van Buren, C. T. Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay. Transplantation 41: 459-464, 1986.
27. Prueksaritanont, T., Correia, M. A., Rettie, A. E., Swinney, D. C., Thomas, P. E., and Benet, L. Z. Cyclosporine metabolism by rat liver microsomes. Evidence for involvement of enzyme(s) other than cytochromes P-450 3A. Drug Metab. Dispos. 21: 730-737., 1993.
28. Pang, K. S., Lee, W. F., Cherry, W. F., Yuen, V., Accaputo, J., Fayz, S., Schwab, A. J., and Goresky, C. A. Effects of perfusate flow rate on measured blood volume, disse space, intracellular water space, and drug extraction in the perfused rat liver preparation: characterization by the multiple indicator dilution technique. J. Pharmacokinet. Biopharm. 16: 595-631, 1988.